Hdm2 inhibitors (Cyclacel)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHdm2 inhibitors (Cyclacel)
Drug Alias NameCYC-700 series (Cyclacel)p53-Mdm2 inhibitors (Cyclacel)p53-Hdm2 inhibitors (Cyclacel)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCyclacel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCyclacel Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A